-
公开(公告)号:EP3348573A1
公开(公告)日:2018-07-18
申请号:EP17195757.4
申请日:2009-04-24
申请人: Dyax Corp. , Biogen Hemophilia Inc.
发明人: TENHOOR, Christopher , MURUGANANDAM, Arumugam , LADNER, Robert, Charles , WOOD, Clive , BITONTI, Alan, J. , STATTEL, James , MCDONNELL, Kevin , LIU, Liming , DUMONT, Jennifer , SATO, Aaron
摘要: This disclosure provides, inter alia , proteins that bind to FcRn, e.g ., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
-
公开(公告)号:EP2310415B8
公开(公告)日:2017-12-13
申请号:EP09734929.4
申请日:2009-04-24
申请人: Dyax Corp. , Biogen Hemophilia Inc.
发明人: TENHOOR, Christopher , MURUGANANDAM, Arumugam , LADNER, Robert, Charles , WOOD, Clive , BITONTI, Alan, J. , STATTEL, James , MCDONNELL, Kevin , LIU, Liming , DUMONT, Jennifer , SATO, Aaron
CPC分类号: C07K16/283 , A61K49/0058 , A61K49/16 , A61K51/1027 , A61K2039/505 , C07K16/28 , C07K2317/20 , C07K2317/21 , C07K2317/33 , C07K2317/34 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , G01N33/68 , G01N33/6854 , G01N2333/70535
-
公开(公告)号:EP2310415B1
公开(公告)日:2017-10-11
申请号:EP09734929.4
申请日:2009-04-24
发明人: TENHOOR, Christopher , MURUGANANDAM, Arumugam , LADNER, Robert, Charles , WOOD, Clive , BITONTI, Alan, J. , STATTEL, James , MCDONNELL, Kevin , LIU, Liming , DUMONT, Jennifer , SATO, Aaron
CPC分类号: C07K16/283 , A61K49/0058 , A61K49/16 , A61K51/1027 , A61K2039/505 , C07K16/28 , C07K2317/20 , C07K2317/21 , C07K2317/33 , C07K2317/34 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , G01N33/68 , G01N33/6854 , G01N2333/70535
-
公开(公告)号:EP3670538A1
公开(公告)日:2020-06-24
申请号:EP19210915.5
申请日:2009-04-24
发明人: TENHOOR,, Christopher , MURUGANANDAM,, Arumugam , LADNER, Robert,, Charles , WOOD,, Clive , BITONTI,, Alan, J. , STATTEL,, James , MCDONNELL, Kevin , LIU,, Liming , DUMONT,, Jennifer , SATO,, Aaron
IPC分类号: C07K16/28 , A61P37/00 , A61K39/395
摘要: This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.
-
公开(公告)号:EP3348573B1
公开(公告)日:2020-04-22
申请号:EP17195757.4
申请日:2009-04-24
-
-
-
-